Boston Scientific Corporation (BSX) — Analyst outlook / Analyst consensus target is. Based on 43 analyst ratings, the consensus is bullish — 1 Strong Buy, 39 Buy, 3 Hold.
The consensus price target is $108.35 (low: $94.00, high: $130.00), representing an upside of 69.8% from the current price $63.82.
Analysts estimate Earnings Per Share (EPS) of $2.47 and revenue of $16.61B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.26 vs est $2.47 (missed -48.9%). 2025: actual $1.96 vs est $3.04 (missed -35.4%). Analyst accuracy: 25%.
BSX Stock — 12-Month Price Forecast
$108.35
▲ +69.77% Upside
Average Price Target
Based on 43 Wall Street analysts offering 12-month price targets for Boston Scientific Corporation, the average price target is $108.35, with a high forecast of $130.00, and a low forecast of $94.00.
The average price target represents a +69.77% change from the last price of $63.82.
Highest Price Target
$130.00
Average Price Target
$108.35
Lowest Price Target
$94.00
BSX Analyst Ratings
Buy
Based on 43 analysts giving stock ratings to Boston Scientific Corporation in the past 3 months
EPS Estimates — BSX
25%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1.26
vs Est $2.47
▼ 95.7% off
2025
Actual $1.96
vs Est $3.04
▼ 54.9% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — BSX
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $16.747B
vs Est $16.609B
▲ 0.8% off
2025
Actual $20.074B
vs Est $20.071B
▲ 0.0% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
